African-Americans constitute 13.1% of the nation’s population, but only 1–2% of its roughly 10,400 oncologists. The percentage of Latino oncologists isn’t much better at 2–3%, given their 16.9% share of U.S. population.
In the fifteen years following a commitment by the National Cancer Institute (NCI) to increase diversity among investigators as well as patients involved in clinical trials, various efforts have emerged to achieve this goal. Three efforts announced in recent weeks offer some hope that years of words will finally give way to deeds when it comes to increasing minority presence among researchers who carry out clinical trials, as well as clinical trial participants. read more